Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Level2View

VCYT
Veracyte, Inc.
stock NASDAQ

At Close
Mar 6, 2026 3:59:51 PM EST
33.86USD-2.364%(-0.82)964,112
0.00Bid   0.00Ask   0.00Spread
Pre-market
Mar 6, 2026 8:55:30 AM EST
33.90USD-2.249%(-0.78)903
After-hours
Mar 6, 2026 4:00:30 PM EST
33.85USD-0.030%(-0.01)10,405
OverviewOption ChainMax PainOptionsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Jan 31, 2022
08:41AM EST  Veracyte Announces New Data to be Presented at the 2022 ASCO Genitourinary (GU) Cancers Symposium   Business Wire
Jan 24, 2022
08:35AM EST  Veracyte Says New Data Suggest Co's Percepta Genomic Sequencing Classifier Can Help Accelerate Timely Treatment For Patients With Early-Stage Lung Cancer   Benzinga
08:30AM EST  New Data Suggest Veracyte's Percepta Genomic Sequencing Classifier Can Help Accelerate Timely Treatment for Patients with Early-Stage Lung Cancer   Business Wire
Jan 7, 2022
01:07PM EST  Benzinga's Top Ratings Upgrades, Downgrades For January 7, 2022   Benzinga
01:01PM EST  Stephens & Co. Initiates Coverage On Veracyte with Overweight Rating, Announces Price Target of $52   Benzinga
Jan 6, 2022
08:30AM EST  Veracyte Announces Key Leadership Promotions to Advance Its Strategic Global Vision   Business Wire
Dec 14, 2021
04:05PM EST  Veracyte Announces Publication of Data Demonstrating Clinical Utility of Its Envisia Genomic Classifier to Improve IPF Diagnosis   Business Wire
Nov 24, 2021
04:35AM EST  Veracyte Says Swedish Medical Technologies Product Council Recommends Prosigna Breast Cancer Assay   RTTNews
04:32AM EST  Veracyte Announces Further European Reimbursement Expansion for Prosigna Breast Cancer Test   Business Wire
Nov 13, 2021
07:00AM EST  Veracyte Announces New Data on Immuno-Oncology Offerings Presented at SITC 2021   Business Wire
Nov 10, 2021
09:19AM EST  Raymond James Maintains Outperform on Veracyte, Raises Price Target to $62   Benzinga
Nov 9, 2021
05:18PM EST  Veracyte Raises FY21 Sales Guidance From $200M-$208M To $210M-$218M vs $205.88M Est.   Benzinga
05:16PM EST  Veracyte Q3 EPS $(0.20) Misses $(0.16) Estimate, Sales $60.37M Beat $54.38M Estimate   Benzinga
11:42AM EST  The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data   Benzinga
11:25AM EST  Earnings Scheduled For November 9, 2021   Benzinga
Nov 5, 2021
09:43AM EDT  Veracyte Announces Immunoscore Colon Cancer Test Included In ESMO Clinical Practice Guidelines Adapted For Pan-Asia   Benzinga
Nov 3, 2021
08:15AM EDT  New Publication Reinforces Clinical Utility of Afirma Genomic Sequencing Classifier in Thyroid Cancer Diagnosis   Business Wire
Nov 2, 2021
10:57AM EDT  Veracyte Announces New Data To Be Presented At SITC 2021 Will Highlight Company's Immuno-Oncology Capabilities Nov. 10-14   Benzinga
08:15AM EDT  Veracyte Announces New Data To Be Presented at SITC 2021 Will Highlight Company's Immuno-Oncology Capabilities   Business Wire
Oct 26, 2021
09:29AM EDT  VCYT: Data Shows Clinical Utility Of Decipher Prostate Genomic Classifier In Tailoring Treatment For Prostate Cancer   RTTNews
09:25AM EDT  New Data Demonstrate Clinical Utility of Veracyte's Decipher Prostate Genomic Classifier in Tailoring Treatment for Prostate Cancer Patients Experiencing Progression After Surgery   Business Wire
Oct 25, 2021
10:42AM EDT  Veracyte:Decipher Prostate Classifier Can Help Physicians& Patients Make Critical Treatment Decisions In Prostate Cancer   RTTNews
10:31AM EDT  Veracyte Highlights Data Presented At ASTRO 2021; Says Data Validate Prognostic Value Of Decipher Prostate Genomic Test In Newly Diagnosed, Clinically High-Risk Prostate Cancer   Benzinga
10:30AM EDT  Data Presented at ASTRO 2021 Validate Prognostic Value of Decipher Prostate Genomic Test in Newly Diagnosed, Clinically High-Risk Prostate Cancer   Business Wire
Oct 14, 2021
08:43AM EDT  Veracyte To Present New Data At ASTRO 2021 Further Validate Clinical Utility Of Decipher Prostate Genomic Classifier   RTTNews
08:39AM EDT  Veracyte Says New Data To Be Presented At ASTRO 2021; Co Says Data Further Validate Clinical Utility Of Veracyte's Decipher Prostate Genomic Classifier   Benzinga
08:35AM EDT  New Data to be Presented at ASTRO 2021 Further Validate Clinical Utility of Veracyte's Decipher Prostate Genomic Classifier   Business Wire
Oct 13, 2021
01:38PM EDT  Veracyte Highlights Publication Of Data On Decipher Bladder Test   Benzinga
09:01AM EDT  Veracyte : Publication Shows Ability Of Decipher Bladder Test To Identify Tumors Most Likely To Respond To Chemotherapy   RTTNews
08:55AM EDT  New Publication Demonstrates Ability of Veracyte's Decipher Bladder Test to Identify Tumors Most Likely to Respond to Chemotherapy   Business Wire
Oct 11, 2021
04:43PM EDT  Veracyte Highlights New Data Showing Its Envisia Genomic Classifier Impacted Clinical-Decision Making In Idiopathic Pulmonary Fibrosis   Benzinga
04:41PM EDT  New Clinical Utility Data Confirm Veracyte's Envisia Genomic Classifier Increases Accuracy and Confidence in IPF Diagnosis   Business Wire
08:16AM EDT  Veracyte Announces New Expanded Data At CHEST; Says Data Underscores Percepta Nasal Swab Test's Ability To Improve Early Lung Cancer Assessment   Benzinga
08:15AM EDT  Veracyte Announces New Expanded Data at CHEST Underscoring Percepta Nasal Swab Test's Ability to Improve Early Lung Cancer Assessment   Business Wire
Oct 6, 2021
08:37AM EDT  Veracyte To Present Data; Shows Performance Of Genomic Diagnostic Tests In Lung Cancer &Interstitial Lung Disease   RTTNews
08:32AM EDT  Veracyte, Inc. To Present Four Abstracts At American College of Chest Physicians Annual Meeting 2021 Oct. 17-20   Benzinga
08:30AM EDT  New Data to be Presented at CHEST 2021 Showcase Clinical Performance of Veracyte's Genomic Diagnostic Tests in Lung Cancer and Interstitial Lung Disease   Business Wire
Sep 15, 2021
07:38AM EDT  The Daily Biotech Pulse: Lilly, Regeneron Ink COVID-19 Drug Deal With US, Regulatory Setback For Calliditas, Theravance To Cut 75% Jobs, 4 IPOs   Benzinga
Sep 14, 2021
04:05PM EDT  Veracyte Announces that New NCCN Guidelines Uniquely Recommend Use of Decipher Prostate Genomic Test Score to Guide Specific Treatment for Men Following Radical Prostatectomy   Business Wire
Sep 1, 2021
08:39AM EDT  Veracyte Appoints Joshua Klopper As Medical Director Of Endocrinology   RTTNews
08:35AM EDT  Veracyte Further Strengthens Medical Team with Appointment of Joshua Klopper, M.D., as Medical Director of Endocrinology   Business Wire
Aug 26, 2021
05:56PM EDT  Where Veracyte Stands With Analysts   Benzinga
Aug 23, 2021
10:33AM EDT  Veracyte Named a San Francisco Bay Area "Top Workplace" for Eighth Consecutive Year   Business Wire
Aug 3, 2021
08:11AM EDT  Veracyte Says Completes HalioDx Acquisition   RTTNews
08:00AM EDT  Veracyte Completes Acquisition of HalioDx   Business Wire
Jul 30, 2021
01:00PM EDT  UPDATE: Needham On Veracyte Price Target Raise Post-Earnings: Firm Highlights Organic Revenue Growth To 77% From 5.7% Q/Q Given Strength From Afirma & Decipher Prostate; Sees Co. 'Positioned To Become One Of The Leaders In Cancer Diagnostics'   Benzinga
12:33PM EDT  Morgan Stanley Maintains Underweight on Veracyte, Lowers Price Target to $42   Benzinga
12:26PM EDT  What 9 Analyst Ratings Have To Say About Veracyte   Benzinga
08:00AM EDT  Needham Maintains Buy on Veracyte, Raises Price Target to $55   Benzinga
04:51AM EDT  SVB Leerink Maintains Outperform on Veracyte, Raises Price Target to $60   Benzinga
Jul 29, 2021
04:38PM EDT  Veracyte Raises FY21 Sales Guidance From $190M-$200M To $200M-$208M Vs. $197.9M Est.   Benzinga
04:37PM EDT  Veracyte Q2 EPS $(0.13) Beats $(0.25) Estimate, Sales $55.10M Beat $48.06M Estimate   Benzinga
08:18AM EDT  The Daily Biotech Pulse: Merck's Disappointing Q2, Atreca Falls On Data, FDA Nod For Viatris, Nuvalent, Icosavax IPOs   Benzinga
04:23AM EDT  Earnings Scheduled For July 29, 2021   Benzinga
Jul 27, 2021
04:24PM EDT  Veracyte Reports New Data Suggests Decipher Prostate Biopsy Genomic Classifier May Help Guide Treatment Decisions For Patients   Benzinga
04:06PM EDT  New Study Suggests Decipher Prostate Biopsy Test May Help Guide Use of Active Surveillance in Prostate Cancer   Business Wire
Jul 25, 2021
10:05AM EDT  The Week Ahead In Biotech (July 25-31): Big Pharma Earnings, Iterum FDA Decision, Alzheimer's Conference, IPOs and More   Benzinga
Jul 14, 2021
07:49AM EDT  SVB Leerink Maintains Outperform on Veracyte, Lowers Price Target to $55   Benzinga
Jul 12, 2021
08:42AM EDT  Veracyte Appoints Rebecca Chambers As Executive Vice President And Chief Financial Officer   Benzinga
Jul 8, 2021
08:37AM EDT  Veracyte Names Rob Brainin EVP And Chief Business Officer And Bill Zondler SVP And Chief Information Officer   RTTNews
08:30AM EDT  Veracyte Announces Key Appointments to Executive Leadership Team, Supporting Global Expansion   Business Wire
Jul 1, 2021
08:45AM EDT  Veracyte Announces Two Pre-Eminent Physician Appointments, Further Strengthening Medical Team   Business Wire
Jun 28, 2021
01:20PM EDT  Expert Ratings For Veracyte   Benzinga
07:30AM EDT  Raymond James Maintains Outperform on Veracyte, Raises Price Target to $50   Benzinga
Jun 25, 2021
10:33AM EDT  Looking Into Veracyte's Return On Capital Employed   Benzinga
Jun 15, 2021
10:24AM EDT  Benzinga's Top Ratings Upgrades, Downgrades For June 15, 2021   Benzinga
08:13AM EDT  Raymond James Initiates Coverage On Veracyte with Outperform Rating, Announces Price Target of $45   Benzinga
Jun 14, 2021
08:56AM EDT  Veracyte Says New Data Demonstrating Prognostic Utility Of Decipher Prostate Genomic Classifier   RTTNews
08:47AM EDT  Veracyte Says New Data Published In JAMA Oncology Demonstrate Prognostic Utility Of Co's Decipher Prostate Genomic Classifier In Locally Advanced Prostate Cancer   Benzinga
08:45AM EDT  New Data Published in JAMA Oncology Demonstrate Prognostic Utility of Veracyte's Decipher Prostate Genomic Classifier in Locally Advanced Prostate Cancer   Business Wire
Jun 9, 2021
10:42AM EDT  Veracyte: Return On Capital Employed Insights   Benzinga
Jun 4, 2021
09:25AM EDT  Veracyte Says Receives Final Medicare Coverage Policies For Decipher Bladder   Benzinga
09:24AM EDT  Veracyte Receives Final Medicare Coverage Policies for Decipher Bladder   Business Wire
Jun 2, 2021
04:27PM EDT  CORRECTING and REPLACING Veracyte to Present at Upcoming Investor Conferences   Business Wire
03:00PM EDT  Veracyte to Present at Upcoming Investor Conferences   Business Wire
Jun 1, 2021
12:22PM EDT  Veracyte Strengthens Cancer Diagnostics Portfolio with HalioDx Acquisition   Benzinga
07:44AM EDT  Veracyte, Inc. (VCYT) announced Tuesday it has agreed to acquire HalioDx in a transaction to further accelerate growth and strengthen Veracyte's global leadership in cancer diagnostics.   RTTNews
07:11AM EDT  Veracyte Agrees To Acquire HalioDx   RTTNews
07:02AM EDT  Veracyte To Acquire HalioDx For 260M In Total   Benzinga
07:00AM EDT  Veracyte to Acquire HalioDx, Positioning for Global Cancer Diagnostics Growth   Business Wire
May 26, 2021
03:00PM EDT  Veracyte to Present at Upcoming Investor Conferences   Business Wire
09:35AM EDT  Veracyte: New Data Show Afirma Xpression Atlas Identifies Clinically Relevant Gene Fusions In Thyroid Cancer FNA Samples   RTTNews
09:10AM EDT  Veracyte To Present Data On Afirma Xpression Atlas At ASCO Jun. 4   Benzinga
09:05AM EDT  Veracyte Announces New Data Demonstrating Afirma Xpression Atlas Identifies Clinically Relevant Gene Fusions in Thyroid Cancer FNA Samples   Business Wire
May 25, 2021
09:18AM EDT  Veracyte Announces New Data Reinforcing Prognostic Utility Of Decipher Prostate Genomic Classifier At ASCO 2021   RTTNews
09:06AM EDT  Veracyte Highlights New Data From 2 Studies That Further Show Decipher Prostate Genomic Classifier   Benzinga
09:00AM EDT  Veracyte Announces New Data at ASCO 2021 Reinforcing Prognostic Utility of Decipher Prostate Genomic Classifier   Business Wire
May 19, 2021
05:25PM EDT  Pharma/Biotech Companies Highlight Upcoming Presentations At American Society Of Clinical Oncology Jun. 4-8, 2021   Benzinga
05:03PM EDT  Veracyte Announces A New Pivotal Clinical Validation Data At The ASCO Showing Noninvasive Nasal Swab Test Can Significantly Improve Early Lung Cancer Detection   Benzinga
May 18, 2021
05:15PM EDT  Veracyte to Present at Upcoming Investor Conferences   Business Wire
09:45AM EDT  Truist Securities Maintains Buy on Veracyte, Lowers Price Target to $55   Benzinga
May 14, 2021
04:35PM EDT  Veracyte Announces Data Reinforcing the Diagnostic Performance and Utility of the Envisia Genomic Classifier in ILD Diagnosis   Business Wire
12:46PM EDT  Veracyte Announces Data Showing Percepta Genomic Atlas Detects Gene Alterations Targeted In Lung Cancer Treatment, Using Diagnostic Biopsy   Benzinga
May 12, 2021
09:31AM EDT  Morgan Stanley Maintains Underweight on Veracyte, Lowers Price Target to $45   Benzinga
May 11, 2021
09:58AM EDT  Expert Ratings for Veracyte   Benzinga
09:00AM EDT  SVB Leerink Maintains Outperform on Veracyte, Lowers Price Target to $65   Benzinga
07:16AM EDT  Needham Maintains Buy on Veracyte, Lowers Price Target to $54   Benzinga
May 10, 2021
04:49PM EDT  Veracyte Reaffirms FY21 Sales Guidance $190M-$200M vs $194.2M Estimate   Benzinga
04:49PM EDT  Veracyte Q1 EPS $(0.11) Beats $(0.12) Estimate, Sales $36.70M Beat $32.67M Estimate   Benzinga
04:30PM EDT  Veracyte Announces Bonnie Anderson, Cofounder and CEO, to Assume Active Role as Executive Chairman; Marc Stapley to Become Chief Executive Officer   Benzinga
04:10PM EDT  Veracyte, Inc. Announces CEO Succession Plan   Business Wire
04:09AM EDT  Earnings Scheduled For May 10, 2021   Benzinga
May 4, 2021
05:30PM EDT  Veracyte Announces New Data Relating to Prosigna Breast Cancer Test to Be Presented at ESMO Breast Cancer Virtual Congress   Benzinga
Apr 29, 2021
08:41AM EDT  Veracyte Says To Unveil Practice-Changing Genomic Diagnostics Data Across Multiple Oncology Indications At 2021 ASCO   Benzinga
Apr 27, 2021
04:58PM EDT  Veracyte Announces Publication of Study Showing Robust Performance of Percepta GSC in Improving Lung Cancer Diagnosis   Benzinga
Apr 20, 2021
01:00PM EDT  Veracyte to Release First Quarter 2021 Financial Results on May 10, 2021   Business Wire
Apr 19, 2021
08:39AM EDT  Veracyte Announces Data For Pulmonology Portfolio To Be Presented At American Thoracic Society 2021 International Conference   Benzinga
Apr 16, 2021
08:01AM EDT  The Daily Biotech Pulse: Precision Biosciences Regains Rights To CAR T Candidates, CFO Changes, 2 IPOs   Benzinga
Apr 15, 2021
04:08PM EDT  Veracyte Sees Q1 Preliminary Sales Guidance Of $36M-$37M Vs $48.73M Estimates   Benzinga
04:06PM EDT  Veracyte Announces The Retirement Of The CEO   Benzinga
04:06PM EDT  Veracyte Announces Retirement of CFO and Preliminary First Quarter 2021 Financial Results   Business Wire
Apr 14, 2021
08:30AM EDT  Veracyte Announces Key Milestone in Companion Diagnostics Program With Acerta Pharma Using LymphMark Lymphoma Subtyping Test   Business Wire
Apr 2, 2021
08:15AM EDT  Veracyte to Present at 20th Annual Needham Virtual Healthcare Conference   Business Wire
Mar 22, 2021
08:17AM EDT  Veracyte Appoints Muna Bhanji To Board   RTTNews
08:15AM EDT  Veracyte Appoints Muna Bhanji to Its Board of Directors   Business Wire
Mar 15, 2021
08:34AM EDT  Veracyte Completes Acquisition Of Decipher Biosciences   RTTNews
Mar 10, 2021
05:15PM EST  Veracyte Commends New USPSTF Lung Cancer Screening Guidelines   Business Wire
Feb 22, 2021
09:55AM EST  Morgan Stanley Maintains Underweight on Veracyte, Raises Price Target to $65   Benzinga
Feb 18, 2021
04:05PM EST  Veracyte to Present at 10th Annual SVB Leerink Global Healthcare Conference   Business Wire
08:14AM EST  The Daily Biotech Pulse: Lily-Rigel Licensing Deal, vTv Starts Early Stage Psoriasis Study, Immunic Data Readout   Benzinga
05:07AM EST  SVB Leerink Maintains Outperform on Veracyte, Raises Price Target to $85   Benzinga
Feb 17, 2021
07:02PM EST  Cathie Wood's ARK Invest Posts Fund Sales For Wednesday, Feb. 17, 2021: GOOGL, CDNA, TWST, VCYT, ONVO, SPLK, SSYS, BYDDY, AVAV, API, PD, PSTG, TCEHY   Benzinga
04:25PM EST  Veracyte: Q4 Earnings Insights   Benzinga
04:13PM EST  Veracyte Sees FY21 Sales $190M-$200M Vs. $151.18M Est.   Benzinga
04:13PM EST  Veracyte Q4 EPS $(0.14) Misses $(0.11) Estimate, Sales $34.50M Beat $31.93M Estimate   Benzinga
04:07PM EST  Veracyte Announces Fourth Quarter and Full-Year 2020 Financial Results   Business Wire
04:34AM EST  Earnings Scheduled For February 17, 2021   Benzinga
Feb 16, 2021
10:13AM EST  Earnings Outlook For Veracyte   Benzinga
Feb 11, 2021
04:05PM EST  Veracyte to Present at BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference   Business Wire
Feb 10, 2021
08:15AM EST  Veracyte to Release Fourth Quarter and Full-Year 2020 Financial Results on February 17, 2021   Business Wire
07:34AM EST  The Daily Biotech Pulse: Lilly COVID-19 Antibody Cocktail Approved for Emergency Use, Gamida, Genfit Jump On Data, 2 IPOs   Benzinga
Feb 9, 2021
04:15PM EST  Veracyte Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares   Business Wire
08:10AM EST  The Daily Biotech Pulse: Dynavax Poaches GSK Vaccine Exec, KalVista Jumps On Data Readout, Corcept Issues Negative Preannouncement   Benzinga
Feb 8, 2021
05:06AM EST  SVB Leerink Maintains Outperform on Veracyte, Raises Price Target to $83   Benzinga
Feb 5, 2021
07:44AM EST  The Daily Biotech Pulse: J&J Files For COVID-19 Vaccine Approval, Zimmer Biomet's Spin-Off, IPO Deluge Hits Street   Benzinga
05:55AM EST  Veracyte Raises $550M In Upsized Equity Offering For Decipher Biosciences Acquisition   Benzinga
Feb 4, 2021
11:25PM EST  Veracyte Prices Public Offering Of 7.43 Mln Shares At $74/Shr   RTTNews
10:45PM EST  Veracyte Announces Pricing of Upsized Public Offering of 7,432,433 Shares of Common Stock   Business Wire
07:22AM EST  The Daily Biotech Pulse: Novartis COVID-19 Drug Readout, Merck And Roche Earnings, 3 IPOs   Benzinga
06:13AM EST  Veracyte Seeks To Raise $400M To Fund Decipher Biosciences Deal   Benzinga
Feb 3, 2021
04:32PM EST  Veracyte Announces Proposed Public Offering of Common Stock   Business Wire
08:13AM EST  Veracyte Scoops Up Decipher Biosciences For $600M, Reports Fourth Quarter Interim Results   Benzinga
07:40AM EST  Genomic diagnostics company Veracyte, Inc. (VCYT) and precision oncology company Decipher Biosciences, Inc. announced Wednesday that they have entered into a definitive agreement through which Veracyte will acquire Decipher for a total consideration of $600 million, consisting of $250 million in cash and up to $350 million in stock, subject to customary purchase price adjustments.   RTTNews
07:37AM EST  Veracyte Expects To Report Q4 Total Revenue Of $34.0 Mln-$35.0 Mln   RTTNews
07:31AM EST  The Daily Biotech Pulse: Amgen Earnings, GSK-CureVac Vaccine Collaboration, Mallinckrodt FDA Decision   Benzinga
07:19AM EST  Veracyte to Acquire Decipher Biosciences; Terms Not Disclosed   Benzinga
07:17AM EST  Veracyte To Acquire Decipher Biosciences For Total Consideration Of $600 Mln   RTTNews
07:05AM EST  Veracyte to Acquire Decipher Biosciences   Business Wire
07:03AM EST  Veracyte Sees Q4 Sales $34M-$35M Vs. $31.75M Est., FY20 Sales $117M-$118M Vs. $114.9M Est.   Benzinga
07:00AM EST  Veracyte Announces Preliminary Fourth Quarter and Full-Year 2020 Financial Results   Business Wire
Jan 28, 2021
10:04AM EST  Benzinga's Top Ratings Upgrades, Downgrades For January 28, 2021   Benzinga
07:15AM EST  Truist Securities Initiates Coverage On Veracyte with Buy Rating, Announces Price Target of $61   Benzinga
Jan 6, 2021
02:00PM EST  Veracyte to Participate in 23rd Annual Needham Virtual Growth Conference   Business Wire
Dec 22, 2020
08:21AM EST  Bayer, Veracyte Announce Collaboration To Advance Precision Oncology Patient Identification Program In Thyroid Cancer   RTTNews
08:17AM EST  Bayer, Veracyte Announce Precision Oncology Collaboration In Thyroid Cancer   Benzinga
Dec 21, 2020
08:26AM EST  Veracyte Reports ISO 13485:2016 Certification For Its In Vitro Diagnostics Quality Management System   RTTNews
08:18AM EST  Veracyte Announces ISO 13485:2016 Certification For Its In Vitro Diagnostics Quality Management System   Benzinga
Dec 16, 2020
12:06PM EST  Veracyte Announces New Preliminary Data For In-Development Lung Cancer Portfolio Tests   Benzinga
Dec 15, 2020
08:18AM EST  Veracyte Expands Collaboration With Lung Cancer Initiative at Johnson & Johnson   RTTNews
08:16AM EST  Veracyte Announces Expansion Of Collaboration With The Lung Cancer Initiative At Johnson & Johnson   Benzinga
Dec 8, 2020
08:04AM EST  The Daily Biotech Pulse: ASH Presentations, Axsome's Positive Midstage Readout, Follow-On Offerings   Benzinga
Dec 4, 2020
08:04AM EST  The Daily Biotech Pulse: BioCryst's Heredity Angioedema Treatment Clears FDA, Sutro Biopharma Readout, 2 IPOs   Benzinga
Dec 3, 2020
02:30PM EST  Veracyte to Host Virtual Lung Cancer R&D Day on Wednesday, December 16, 2020   Business Wire
Dec 2, 2020
07:35AM EST  The Daily Biotech Pulse: Pfizer-BioNTech Vaccine Gets Temporary UK Authorization, Ovid's Trial Disappointment, Vanda Snags FDA Nod   Benzinga
Dec 1, 2020
08:08AM EST  The Daily Biotech Pulse: Pfizer, BioNTech File Marketing Application In Europe, NuCana Jumps On Data, Amarin Takes On Hikma In Patent Lawsuit   Benzinga
Nov 25, 2020
07:35AM EST  The Daily Biotech Pulse: Revance's DAXI Regulatory Decision, Reata Slips On FDA Feedback, Liquidia Setback   Benzinga
Nov 24, 2020
08:13AM EST  The Daily Biotech Pulse: Alnylam's Oxluma Snags Early FDA Approval, DBV Chief Scientific Officer To Depart, Decision Day For Liquidia   Benzinga
Nov 23, 2020
04:05PM EST  Veracyte to Participate in Piper Sandler 32nd Annual Virtual Healthcare Conference   Business Wire
Nov 20, 2020
08:06AM EST  The Daily Biotech Pulse: Amarin Surges On Vascepa Data, Mesoblast Rallies On Novartis Deal, Decision Day For Eiger   Benzinga
Nov 19, 2020
08:17AM EST  The Daily Biotech Pulse: Aquestive's Positive FDA Meeting, Prevail Awarded Patent, Neuro-Oncology Conference Gets Underway   Benzinga
Nov 17, 2020
09:47AM EST  Veracyte Announces New General Manager Structure To Advance Global Expansion   Benzinga
08:32AM EST  The Daily Biotech Pulse: Setback For Alkermes, Boston Scientific's Recall, ALX-Zymeworks Oncology Collaboration   Benzinga
08:30AM EST  Veracyte Announces New General Manager Structure to Advance Global Expansion   Business Wire
Nov 13, 2020
07:40AM EST  The Daily Biotech Pulse: Urovant In M&A Deal, Sanofi's Binary Event, Conference Presentations   Benzinga
Nov 12, 2020
07:44AM EST  The Daily Biotech Pulse: AstraZeneca's Cancer Drug Flunks COVID-19 Studies, Five Prime On a Roll, Morphosys, Xencor, Incyte Strike Cancer Deal   Benzinga
Nov 10, 2020
08:40AM EST  The Daily Biotech Pulse: Lilly's COVID-19 Antibody Treatment Approved For Emergency Use, Supernus Faces Twin Regulatory Setbacks, Revance, Arena Flunk Midstage Studies   Benzinga
Nov 4, 2020
08:30AM EST  BTIG Maintains Buy on Veracyte, Raises Price Target to $42   Benzinga
Nov 3, 2020
09:18AM EST  10 Biggest Price Target Changes For Tuesday   Benzinga
07:40AM EST  Needham Maintains Buy on Veracyte, Raises Price Target to $40   Benzinga
04:09AM EST  SVB Leerink Maintains Outperform on Veracyte, Raises Price Target to $40   Benzinga
Nov 2, 2020
04:29PM EST  Veracyte Q3 EPS $(0.08) Beats $(0.21) Estimate, Sales $31.10M Beat $23.88M Estimate   Benzinga
04:06PM EST  Veracyte Announces Third Quarter 2020 Financial Results   Business Wire
07:55AM EST  Earnings Scheduled For November 2, 2020   Benzinga
Nov 1, 2020
09:40AM EST  The Week Ahead In Biotech (Nov. 1-7): Adcom Test For Biogen's Aducanumab, Alzheimer's Conference, SMID-cap Earnings   Benzinga
Oct 30, 2020
08:19AM EDT  Veracyte Announces New Data Published In Journal Of Clinical Oncology Suggest The Prosigna Breast Cancer Test's Genomic Underpinning Drives Prognostic Performance   Benzinga
Oct 22, 2020
04:07PM EDT  Veracyte Announces Publication Of Manuscript Describing Scientific Rigor Behind Percepta Genomic Sequencing Classifier   Benzinga
04:05PM EDT  Veracyte Announces Publication of Manuscript Describing Scientific Rigor Behind Next-Generation Percepta Genomic Sequencing Classifier   Business Wire
Oct 19, 2020
08:18AM EDT  Veracyte Highlights Presentation Of Data At CHEST Annual Meeting 'Reinforcing Foundational Technology of Nasal Swab Test for Early Lung Cancer Detection'   Benzinga
08:15AM EDT  Veracyte Announces New Data Reinforcing Foundational Technology of Nasal Swab Test for Early Lung Cancer Detection Presented at CHEST Annual Meeting 2020   Business Wire
Oct 14, 2020
04:05PM EDT  Veracyte Announces Two Presentations to Be Shared at CHEST Annual Meeting 2020   Business Wire
Oct 7, 2020
08:15AM EDT  Veracyte to Release Third Quarter 2020 Financial Results on November 2, 2020   Business Wire
Sep 24, 2020
08:20AM EDT  Veracyte Receives ADLT Status for Envisia Genomic Classifier From Centers for Medicare and Medicaid Services   Benzinga
Sep 15, 2020
04:30PM EDT  Veracyte to Present at Two Investor Conferences   Business Wire
Sep 14, 2020
02:37PM EDT  Veracyte Promotes Richard Kloos To Executive Medical Director   RTTNews
01:45PM EDT  Veracyte Announces Promotion of Richard T. Kloos, M.D. To Executive Medical Director   Business Wire
Sep 11, 2020
08:22AM EDT  Veracyte Initiates Consensus Study Exploring Medical Utility Of Multiple Breast Cancer Genomic Tests   RTTNews
08:15AM EDT  Veracyte Reports Initiation Of Consensus Study Exploring Medical Utility Of Multiple Breast Cancer Genomic Tests   Benzinga
08:15AM EDT  Veracyte Announces Initiation of Consensus Study Exploring Medical Utility of Multiple Breast Cancer Genomic Tests   Business Wire
Sep 9, 2020
09:45AM EDT  Benzinga's Top Upgrades, Downgrades For September 9, 2020   Benzinga
08:20AM EDT  Morgan Stanley Initiates Coverage On Veracyte with Underweight Rating, Announces Price Target of $35   Benzinga
Sep 4, 2020
08:15AM EDT  Veracyte to Present at Upcoming Investor Conferences   Business Wire
Aug 24, 2020
08:15AM EDT  Veracyte Named a San Francisco Bay Area "Top Workplace" for Seventh Consecutive Year   Business Wire
Aug 7, 2020
04:28PM EDT  Veracyte Announces Closing Of Public Offering Of Common Stock   RTTNews
04:15PM EDT  Veracyte Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares   Business Wire
Aug 5, 2020
04:15PM EDT  Veracyte Announces New Real-World Data Reinforcing the Potential Clinical Value of Percepta and Envisia Classifiers to Improve Diagnosis of Serious Lung Diseases   Business Wire
08:15AM EDT  Veracyte Announces Positive Clinical Utility Data for Percepta Classifier Published in CHEST   Business Wire
Aug 4, 2020
07:29PM EDT  Veracyte Announces Pricing of Public Offering of 6,000,000 Shares of Common Stock   Business Wire
Aug 3, 2020
04:29PM EDT  Veracyte Announces Proposed Public Offering of 6M Shares Of Common Stock   Benzinga
04:10PM EDT  Veracyte Announces Proposed Public Offering of Common Stock   Business Wire
Jul 31, 2020
06:40AM EDT  SVB Leerink Maintains Outperform on Veracyte, Raises Price Target to $37   Benzinga
06:36AM EDT  Needham Maintains Buy on Veracyte, Raises Price Target to $37   Benzinga
Jul 30, 2020
04:35PM EDT  Veracyte Q2 EPS $(0.22) Beats $(0.24) Estimate, Sales $20.70M Beat $20.60M Estimate   Benzinga
04:06PM EDT  Veracyte Announces Second Quarter 2020 Financial Results   Business Wire
08:24AM EDT  Veracyte Highlights Data Published In AJRCCM Showing That 'the Envisia Genomic Classifier Improves Physicians' Ability to Diagnose IPF Without Surgery'   Benzinga
08:15AM EDT  Veracyte Announces Data Published in AJRCCM Showing That the Envisia Genomic Classifier Improves Physicians' Ability to Diagnose IPF Without Surgery   Business Wire
04:06AM EDT  Earnings Scheduled For July 30, 2020   Benzinga
Jul 29, 2020
08:41AM EDT  Veracyte Inc. (VCYT) and MAVIDx have reached an agreement by which MAVIDx will develop ultra-high throughput genomic testing for SARS-CoV-2, the virus that causes COVID-19, on the nCounter Analysis System, Veracyte's diagnostics platform, Veracyte said in a statement.   RTTNews
08:23AM EDT  Veracyte, MAVIDx Announce Agreement For MAVIDx To Develop Ultra-High Volume Coronavirus Testing On nCounter System   Benzinga
08:21AM EDT  Veracyte And MAVIDx Agree To Develop Ultra-High Volume COVID-19 Testing On The NCounter System   RTTNews
08:15AM EDT  Veracyte and MAVIDx Announce Agreement for MAVIDx to Develop Ultra-High Volume COVID-19 Testing on the nCounter System   Business Wire
Jul 27, 2020
08:19AM EDT  Veracyte Appoints James Erlinger As EVP General Counsel And Secretary   RTTNews
08:15AM EDT  Veracyte Appoints Jens Holstein to Board of Directors and James (Jim) Erlinger as Executive Vice President, General Counsel and Secretary   Business Wire
Jul 16, 2020
08:15AM EDT  Veracyte to Release Second Quarter 2020 Financial Results on July 30, 2020   Business Wire


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-5
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC